JP2010500871A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500871A5
JP2010500871A5 JP2009522979A JP2009522979A JP2010500871A5 JP 2010500871 A5 JP2010500871 A5 JP 2010500871A5 JP 2009522979 A JP2009522979 A JP 2009522979A JP 2009522979 A JP2009522979 A JP 2009522979A JP 2010500871 A5 JP2010500871 A5 JP 2010500871A5
Authority
JP
Japan
Prior art keywords
composition
cell
sertoli
cells
neonatal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009522979A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500871A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/074623 external-priority patent/WO2008014470A2/en
Publication of JP2010500871A publication Critical patent/JP2010500871A/ja
Publication of JP2010500871A5 publication Critical patent/JP2010500871A5/ja
Pending legal-status Critical Current

Links

JP2009522979A 2006-07-28 2007-07-27 成熟セルトリ細胞およびその使用 Pending JP2010500871A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82076006P 2006-07-28 2006-07-28
PCT/US2007/074623 WO2008014470A2 (en) 2006-07-28 2007-07-27 Adult sertoli cells and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013245122A Division JP2014074041A (ja) 2006-07-28 2013-11-27 成熟セルトリ細胞およびその使用

Publications (2)

Publication Number Publication Date
JP2010500871A JP2010500871A (ja) 2010-01-14
JP2010500871A5 true JP2010500871A5 (https=) 2012-02-09

Family

ID=38982397

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009522979A Pending JP2010500871A (ja) 2006-07-28 2007-07-27 成熟セルトリ細胞およびその使用
JP2013245122A Ceased JP2014074041A (ja) 2006-07-28 2013-11-27 成熟セルトリ細胞およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013245122A Ceased JP2014074041A (ja) 2006-07-28 2013-11-27 成熟セルトリ細胞およびその使用

Country Status (6)

Country Link
US (1) US20090191167A1 (https=)
EP (1) EP2046351A2 (https=)
JP (2) JP2010500871A (https=)
AU (1) AU2007278850B2 (https=)
CA (1) CA2658951A1 (https=)
WO (1) WO2008014470A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118145A1 (en) * 2003-07-03 2005-06-02 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
EA025142B1 (ru) 2009-08-28 2016-11-30 Сернова Корпорэйнш Способ и устройство для клеточной трансплантации
JP6293569B2 (ja) * 2014-04-25 2018-03-14 愛三工業株式会社 液面検出装置

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5958404A (en) * 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US5849285A (en) * 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
DE69525151T2 (de) * 1994-04-13 2002-08-14 Research Corp. Technologies, Inc. Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
US5759536A (en) * 1994-05-27 1998-06-02 University Technology Corporation Use of fas ligand to supress T-lymphocyte-mediated immune responses
MX9706062A (es) * 1995-02-08 1997-10-31 Yamanouchi Europ Bv FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA.
US5830460A (en) * 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US20040086494A1 (en) * 1996-10-07 2004-05-06 John Constance Mary Immune privileged cells for delivery of proteins and peptides
US20020065212A1 (en) * 1996-11-08 2002-05-30 Selawry Helena P. Methods of treating disease using sertoli cells and allografts or xenografts
ES2338076T3 (es) * 1998-11-06 2010-05-03 Sertoli Technologies, Inc. Produccion de un factor biologico y creacion de un entorno inmunologicamente privilegiado usando celulas de sertoli alteradas geneticamente.
CA2355675C (en) * 1998-12-15 2006-07-04 Universidad Nacional Autonoma De Mexico Process and device for facilitating the implantation of biological material
US6303355B1 (en) * 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
ES2272482T3 (es) * 2000-01-20 2007-05-01 Diabcell Pty Limited Preparacion y xenotransplante de islotes porcinos.
US6790441B1 (en) * 2000-06-13 2004-09-14 University Of South Florida Sertoli cells as biochambers
US20040014212A1 (en) * 2000-10-17 2004-01-22 Elliott Robert Bartlett Preparation and xenotransplantation or porcine islets
KR20030096381A (ko) * 2001-05-11 2003-12-24 오쏘-맥네일 파머슈티칼 인코퍼레이티드 동물에 사용하기 위한 면역 조절장치
CN1791670A (zh) * 2003-06-24 2006-06-21 戴伯塞尔有限公司 用于异种移植的用猪支持细胞培养的猪胰岛
US20050118145A1 (en) * 2003-07-03 2005-06-02 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US20060182722A1 (en) * 2005-02-11 2006-08-17 Hering Bernhard J Methods and materials for isolating isogenic islet cells

Similar Documents

Publication Publication Date Title
Qian et al. Immunoregulation in diabetic wound repair with a photoenhanced glycyrrhizic acid hydrogel scaffold
Cho et al. A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus
Zang et al. Mesenchymal stem cell therapy in type 2 diabetes mellitus
Wang et al. Pancreatic islet transplantation: current advances and challenges
Rani et al. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications
Shokravi et al. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
Berardis et al. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects
Sun et al. Bioactive fiber-reinforced hydrogel to tailor cell microenvironment for structural and functional regeneration of myotendinous junction
Hao et al. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats
Zhu et al. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice
Tang et al. Injectable and in situ crosslinkable gelatin microribbon hydrogels for stem cell delivery and bone regeneration in vivo
Gu et al. Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats
Lee et al. Human β-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies
Che et al. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
Orlando et al. Cell and organ bioengineering technology as applied to gastrointestinal diseases
Abreu et al. Bone marrow-derived mononuclear cells vs. mesenchymal stromal cells in experimental allergic asthma
Xu et al. Optimization of timing and times for administration of atorvastatin-pretreated mesenchymal stem cells in a preclinical model of acute myocardial infarction
Li et al. Mesenchymal stem cell-based therapy for diabetes mellitus: enhancement strategies and future perspectives
Takahashi et al. Regenerative and transplantation medicine: cellular therapy using adipose tissue-derived mesenchymal stromal cells for type 1 diabetes mellitus
Huan et al. Hydrogel-encapsulated pancreatic islet cells as a promising strategy for diabetic cell therapy
KR20150028754A (ko) 화학요법을 받은 환자용 어주번트를 제조하기 위한 조성물
Tang et al. Mesenchymal stem cells and their small extracellular vesicles as crucial immunological efficacy for hepatic diseases
Ihara et al. Adipose-derived stem cells attenuate pulmonary microvascular hyperpermeability after smoke inhalation
Lorenzini et al. Stem cells for end stage liver disease: how far have we got?
Zhou et al. Subcutaneous device-free islet transplantation